bARBARA s. fANT, pharm.D.



Barbara Fant, Pharm.D. is the President and Principal Regulatory Consultant of Clinical Research Consultants, Inc. (CRC), and has 30 years of experience in pharmaceutical and medical device research and development.  Prior to founding CRC, Dr. Fant spent several years directing and managing anti-infective clinical trials and pharmacokinetic studies with a major pharmaceutical company; established and directed a highly successful Phase I/Phase II academic-based clinical pharmacology research center at the University of Cincinnati; served as the Vice Chairperson and Associate  Administrator for an independent institutional review board; and, was an Assistant Director for Clinical Research for a large contract research organization.  Dr. Fant is nationally and internationally recognized as an expert provider of FDA regulatory and clinical services for the development and approval of corneal, refractive, intraocular, and other ophthalmic medical devices. She has 20 years of experience in working with FDA in the management of LASIK clinical studies and excimer laser regulatory submissions for LASIK, corneal collagen cross-linking, artificial iris, and other refractive and corneal indications; and has successfully filed over a hundred IDE’s, pre-IDE’s, 510(k)’s, and PMA’s with the FDA to bring investigational products to the marketplace. Dr. Fant is also well known for her international regulatory expertise, having served as the ophthalmic technical reviewer for one of the most highly respected notified bodies in Europe for awarding CE mark certification.